Aseptic services
Methotrexate: informing intrathecal risk assessment
29 October 2025Methotrexate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Etoposide: informing intrathecal risk assessment
29 October 2025Etoposide products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Rituximab: informing intrathecal risk assessment
29 October 2025Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Gentamicin: informing intrathecal risk assessment
29 October 2025Gentamicin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Thiotepa: informing intrathecal risk assessment
29 October 2025Thiotepa products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Diamorphine hydrochloride: informing intrathecal risk assessment
29 October 2025Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Colistimethate sodium: informing intrathecal risk assessment
2 October 2025Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Vancomycin: informing intrathecal risk assessment
1 October 2025Vancomycin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Management Review and KPIs
17 November 2025An SPS Quality Assurance (QA) bite size learning event on Management Quality Review and Key Performance Indicators in pharmacy technical services.
Corrective and preventive actions in aseptic services
23 October 2025An SPS Quality Assurance (QA) bite size learning event on corrective and preventive actions (CAPA) in aseptic services.